Methods and compositions involving microRNA

Details for Australian Patent Application No. 2005250432 (hide)

Owner Asuragen, Inc.

Inventors Goldrick, Marianna; Brown, David; Shelton, Jeffrey; Labourier, Emmanuel; Conrad, Rick; Powers, Patricia; Shingara, Jaclyn; Devroe, Eric; Moon, Ivonne; Keiger, Kerri

Agent Pizzeys

Pub. Number AU-B-2005250432

PCT Pub. Number WO2005/118806

Priority 60/575,743 28.05.04 US; 60/649,584 03.02.05 US

Filing date 31 May 2005

Wipo publication date 15 December 2005

Acceptance publication date 15 September 2011

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 27/447 (2006.01) Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means - using electrophoresis

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2005/118806 Priority application(s): WO2005/118806

14 June 2007 Assignment before Grant

  Ambion, Inc. The application has been assigned to Asuragen, Inc.

15 September 2011 Application Accepted

  Published as AU-B-2005250432

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005250437-1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoro methyl)-3-pentanone refrigerant compositions and uses thereof

2005250430-Stable peptide mimetic of HIV gp41 fusion intermediate